Rethinking Schistosomiasis Vaccine Development
dc.contributor.author | Egesa, Moses | |
dc.contributor.author | Hoffmann, Karl F. | |
dc.contributor.author | Yazdanbakhsh, Maria | |
dc.contributor.author | Cose, Stephen | |
dc.date.accessioned | 2023-06-22T19:06:09Z | |
dc.date.available | 2023-06-22T19:06:09Z | |
dc.date.issued | 2017 | |
dc.description.abstract | There is currently no vaccine against schistosomiasis. With few Schistosoma vaccine candidates in clinical trials, unexplored antigens from the vulnerable schistosomulum should be considered as possible vaccine candidates. In addition, we suggest developing synthetic vesicles as a new delivery vehicle and adjuvant for immunoprophylactic schistosomula vaccine candidates. | en_US |
dc.identifier.citation | Egesa, M., Hoffmann, K. F., Hokke, C. H., Yazdanbakhsh, M., & Cose, S. (2017). Rethinking schistosomiasis vaccine development: synthetic vesicles. Trends in parasitology, 33(12), 918-921.https://doi.org/10.1016/j.pt.2017.07.007https://doi.org/10.1016/j.pt.2017.07.007 | en_US |
dc.identifier.issn | 1471-4922 | |
dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/8973 | |
dc.language.iso | en | en_US |
dc.publisher | Trends in parasitology | en_US |
dc.subject | Schistosoma | en_US |
dc.subject | Adjuvant | en_US |
dc.subject | Schistosomula | en_US |
dc.subject | Delivery | en_US |
dc.subject | Vaccine candidates | en_US |
dc.subject | Synthetic vesicles | en_US |
dc.title | Rethinking Schistosomiasis Vaccine Development | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Rethinking Schistosomiasis Vaccine Development Synthetic Vesicles.pdf
- Size:
- 1.08 MB
- Format:
- Adobe Portable Document Format
- Description:
- Rethinking Schistosomiasis Vaccine Development: Synthetic Vesicles
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: